Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × tanespimycin × Clear all

NCT00093496 2014-05-20

Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer

Phase 2 Completed

29 enrolled 9 charts

Carcinoma, Ovarian Epithelial